Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, presenting promising progress across different clinical and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, extra trusted alternative for therapeutic use, notably